Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ADBE | Common Stock | Options Exercise | $0 | +104K | +31.32% | $0.00 | 436K | Jan 24, 2022 | by trust | F1 |
transaction | ADBE | Common Stock | Tax liability | -$26.8M | -51.5K | -11.82% | $519.66 | 384K | Jan 24, 2022 | by trust | F1, F2 |
transaction | ADBE | Common Stock | Options Exercise | $0 | +52K | +13.52% | $0.00 | 436K | Jan 24, 2022 | by trust | F1 |
transaction | ADBE | Common Stock | Tax liability | -$13.4M | -25.8K | -5.91% | $519.66 | 411K | Jan 24, 2022 | by trust | F1, F2 |
transaction | ADBE | Common Stock | Options Exercise | $0 | +2.58K | +0.63% | $0.00 | 413K | Jan 24, 2022 | by trust | F1 |
transaction | ADBE | Common Stock | Tax liability | -$668K | -1.29K | -0.31% | $519.66 | 412K | Jan 24, 2022 | by trust | F1, F2 |
transaction | ADBE | Common Stock | Options Exercise | $0 | +1.76K | +0.43% | $0.00 | 414K | Jan 24, 2022 | by trust | F1 |
transaction | ADBE | Common Stock | Tax liability | -$453K | -871 | -0.21% | $519.66 | 413K | Jan 24, 2022 | by trust | F1, F2 |
transaction | ADBE | Common Stock | Options Exercise | $0 | +5.23K | +1.27% | $0.00 | 418K | Jan 24, 2022 | by trust | F1 |
transaction | ADBE | Common Stock | Tax liability | -$1.35M | -2.59K | -0.62% | $519.66 | 415K | Jan 24, 2022 | by trust | F1, F2 |
holding | ADBE | Common Stock | 74.8 | Jan 24, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ADBE | Performance Shares | Options Exercise | $0 | -104K | -100% | $0.00* | 0 | Jan 24, 2022 | Common Stock | 104K | $0.00 | Direct | F3 |
transaction | ADBE | Performance Shares | Options Exercise | $0 | -52K | -100% | $0.00* | 0 | Jan 24, 2022 | Common Stock | 52K | $0.00 | Direct | F3 |
transaction | ADBE | Restricted Stock Units | Options Exercise | $0 | -2.58K | -20% | $0.00 | 10.3K | Jan 24, 2022 | Common Stock | 2.58K | $0.00 | Direct | F4 |
transaction | ADBE | Restricted Stock Units | Options Exercise | $0 | -1.76K | -11.11% | $0.00 | 14.1K | Jan 24, 2022 | Common Stock | 1.76K | $0.00 | Direct | F5 |
transaction | ADBE | Restricted Stock Units | Options Exercise | $0 | -5.23K | -25% | $0.00 | 15.7K | Jan 24, 2022 | Common Stock | 5.23K | $0.00 | Direct | F6 |
transaction | ADBE | Performance Shares | Award | $0 | +93.6K | $0.00 | 93.6K | Jan 24, 2022 | Common Stock | 93.6K | $0.00 | Direct | F7, F8 | |
transaction | ADBE | Restricted Stock Units | Award | $0 | +20.1K | $0.00 | 20.1K | Jan 24, 2022 | Common Stock | 20.1K | $0.00 | Direct | F9 |
Id | Content |
---|---|
F1 | Shares held by The Narayen Family Trust, dtd 11/30/00 of which reporting person is a trustee. |
F2 | Shares surrendered to pay tax liability due at vesting. |
F3 | The Performance Shares vested in full upon the certification of performance goal achievement at 168% following the three-year anniversary of the January 24, 2019 vesting commencement date. |
F4 | Vests 25% on the first anniversary of the January 24, 2019 vesting commencement date and then 6.25% quarterly thereafter. |
F5 | Vests 25% on the first anniversary of the January 24, 2020 vesting commencement date and then 6.25% quarterly thereafter. |
F6 | Vests 25% on the first anniversary of the January 24, 2021 vesting commencement date and then 6.25% quarterly thereafter. |
F7 | Represents 200% of the target payout (the maximum number of Performance Shares that will be earned, if at all) following the three-year performance period. |
F8 | The Performance Shares will vest in full upon the certification of performance goal achievements following the three-year anniversary of the January 24, 2022 vesting commencement date if the performance goals are achieved. |
F9 | Vests 25% on the first anniversary of the January 24, 2022 vesting commencement date and then 6.25% quarterly thereafter. |